© 2023 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
The U.S. supplements industry has lost some credibility with media and consumers. Could a proposal based on the pharmaceutical industry that is not premarket approval help to alleviate concerns?
By Mark A. LeDoux, Natural Alternatives International Inc.
The past several months have seen a lot of activity in the dietary supplement industry in the United States. One of the precipitating events that caused significant media attention was the Office of the Attorney General of New York’s (NY AG)
issuance of cease-and-desist orders to four retailers in his state
, presumably to remove herbal extract products that did not meet label claims. These retailers are national chains, so the NY AG’s actions immediately got some serious press coverage. Supplement industry leaders have largely criticized the Attorney General’s office, which, in its investigation, contracted with a Canadian firm to initiate DNA testing on finished herbal extract products-
a method which has not been widely used or validated by industry in the United States
, and, frankly, elsewhere.
As of this date, one retailer has negotiated out of the cease-and-desist and has resumed selling products. Some in industry believe that the settlement with the NY AG was premature; others believe it was a reasonable action in light of mounting class action lawsuits filed against the several targets of this investigation. The ensuing discussions in the press, the concerns expressed by doctors and media alike regarding the “unregulated” industry, reached a cacophony of sorts, and the resultant impact has been a reduction of consumer confidence, as measured by a recent Nutrition Business Journal study.
It is not my intent to cast opinion or judgment on the players in this drama, but rather to suggest a way to help alleviate the ongoing lament of often ill-informed media that the dietary supplement industry is unregulated by FDA. Those of us in industry know this is not the case, as do the recipients of warning letters and recall notices by the agency. The consumer does not know this, however, and therein lies the difficulty in assuaging consumer concerns and restoring credibility.
The facts are as follows:
Could the National Drug CodeServe as a Role Model?
Consumers want to believe that the supplements they use are safe, pure, effective, and unadulterated. I choose my words carefully, because that is the type of language that FDA utilizes when it discovers a serious problem with a product in the field. So how can we deliver the assurance of safety, purity, and efficacy? A system implemented by the pharmaceutical industry could hold the answer.
When one goes to purchase over-the-counter medication, on every consumer package is a code number that ties directly into a database managed by FDA. This is called the National Drug Code, or NDC Labeler Code (NDC). On a bottle of Aleve (naproxen sodium) or a generic version thereof, one finds on the front label of the container the following (using two generic versions sourced at Costco and Walgreens as examples):
So what is this NDC Labeler Code number, and what does it mean?
The NDC Labeler Code is a 10-digit, unique, three-segment number that serves as a product identifier for human drugs. The NDC will be in one of the following configurations: 4-4-2, 5-3-2, or 5-4-1.
The first segment of the NDC Labeler Code identifies the establishment; FDA will assign this number, and it will be unique to each establishment (manufacturer, packer, labeler, etc.). The second segment of the NDC Labeler Code identifies the drug (strength, dosage, and formulation). The third segment of the NDC Labeler Code identifies the package size and package type. The second and third segments are assigned by the labeler. An assignment of a NDC number does not denote FDA approval of the product.
It became clear to me that a system not unlike the NDC Labeler Code could be envisioned for the dietary supplement industry in the United States.
I would suggest the time is right to develop a National Dietary Supplement (NDS) Labeler Code system, which would identify each establishment (manufacturer, packer, labeler, etc.) and identify the dietary supplement itself, and the final part of the code would identify the package size and type. Each NDS Code would be unique to each product, because even in commodity products such as vitamin C 500-mg tablets, the manufacturer, packer, labeler, etc., would be clearly spelled out in code within the NDS number. At a point in time sufficient to allow for label compliance and stock conversion, failure to list the NDS number will render the product mislabeled under statute and subject to market withdrawal either voluntarily or via justifiable seizure.
This database would be paid for by industry with nominal user fees, so the end result would be that products would properly appear to be registered with the FDA or some other U.S. government entity if the FDA is not the proper agency to manage this. A centralized database could be accessible to government authorities interested in tracking products that demonstrated a postmarket problem, as well as to consumers, physicians, and industry, just as it is now with the NDC system.
The objective here is twofold:
No Need for Premarket Approval
There is no need to amend the Dietary Supplement Health and Education Act governing supplements to include premarket approval. There is clearly no need to open Pandora’s Box, but there is a need to restore consumer confidence, and I believe the time is right to initiate the creation of the National Dietary Supplement Registry with leaders in the responsible dietary supplement industry.
Here is what I believe are appropriate steps necessary to achieve this goal:
This is an idea whose time has come. After a certain date prescribed by legislation for the system to take effect, it will become important to advertise that products without the NDS code are presumed to be illegal and as such should be avoided. This will also require training of retailers as well as distributors who will not want to be subjected to unnecessary legal issues. Finally, the news media and the print, radio, and television/cable outlets need to be advised that airing or printing commercial content for dietary supplements without the appropriate NDS Code will result in financial penalties to them for aiding and abetting consumer fraud.
Let’s give the attorneys general an opportunity to help police the marketplace by searching for illegal or contraband product rather than go through what we have experienced since February following the NY AG investigation.
I welcome your feedback and comments.
Mark A. LeDoux is chairman and CEO of Natural Alternatives International Inc. (San Marcos, CA).
Editorial: Turning Up the Volume on Dietary Supplement Quality Control
Should FDA’s Dietary Supplement GMPs Include Ingredient Suppliers?